Federal Schedule III Reclassification Prompts State-Level Medical Cannabis Expansion and Regulatory Adjustments

The reclassification of state-licensed medical cannabis to Schedule III under the Controlled Substances Act by the Trump administration has initiated a period of potential regulatory reform across U.S. states, aiming to facilitate medical cannabis expansion. This federal policy shift, signed by…